Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

This research contradicts previous concerns about the potential of drugs like Ozempic to trigger suicidal ideation and ...

Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...

The company has committed £279 million ($364 million) to support national efforts aimed at reducing obesity, a critical ...

In an email to trust leaders today NHS England chief executive Amanda Pritchard stressed the need to transform the way ...

The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

People sense millisecond shifts in odor as quickly as they might spot a change in color, new research shows. The study ...

With millions of Americans taking GLP-1 medications for weight loss, the thought of taking one of these medications might ...

Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

In a bid to combat obesity and unemployment, the UK govt is collaborating with Eli Lilly, which will invest £279 mn in a ...

DEMAND for fat jabs could overwhelm the NHS, the head of the health service has warned as Sir Keir Starmer piled hopes on using them to get obese jobseekers back to work. Amanda Pritchard, CEO of ...